Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

Filiaciones

Bykerk VP:

Inflammatory Arthritis Center, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.

Department of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada.

Östör AJK:

Department of Rheumatology, Cabrini Medical Centre, Melbourne, Victoria, Australia

Alvaro-Gracia J:

Rheumatology Service, Hospital General Universitario Gregorio Marañon, Universidad Complutense Madrid, Madrid, Spain

Pavelka K:

Institute of Rheumatology and Clinic of Rheumatology, Charles University, Prague, Czech Republic

Román Ivorra JA:

Rheumatology Service, Division of Rheumatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Luder Y:

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Sidiropoulos PNM:

Genentech, Inc., South San Francisco, CA, USA

Devenport J:

Genentech, Inc., South San Francisco, CA, USA

Sibilia J:

Department of Rheumatology, CHU Hautepierre, Strasbourg, France